Celldex Therapeutics (CLDX) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

CLDX is expected to report earnings to rise 12.96% to -61 cents per share on November 06

Celldex Therapeutics CLDX Stock Earnings Reports

Q3'24

Est.

$-0.61

Q2'24

Beat

by $0.05

Q1'24

Beat

by $0.15

Q4'23

Missed

by $0.07

Q3'23

Missed

by $0.13

The last earnings report on August 08 showed earnings per share of -54 cents, beating the estimate of -58 cents. With 1.37M shares outstanding, the current market capitalization sits at 2.20B.

View a ticker or compare two or three

Compare

CLDX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For CLDX
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for CLDX (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a developer of immunotherapy technologies for the treatment of cancer and other diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

53 Frontage Road

Phone

+1 908 200-7500

Employees

160

Web

https://www.celldex.com